About the compound
Khavinson pentapeptide bioregulator KEDAD. Reported MW ~561.56 Da.
Vesilute is a Khavinson pentapeptide; vendor materials report the sequence KEDAD. Reported MW ~561.56 Da. Sequence assignment should be confirmed against vendor CoA.
Reconstitution. For in-vitro laboratory handling, dissolve with bacteriostatic water (0.9% benzyl alcohol). Compound is hygroscopic — handle in low-humidity conditions and re-cap immediately.
Stability profile. Lyophilized: stable at room temperature for up to 30 days sealed; long-term storage at -20 °C recommended. Reconstituted material: stable at 2–8 °C for up to 14 days.
Selected primary literature.
- Khavinson VK & Anisimov VN, 2009, Front Neuroendocrinol 30(2):199 — review of the Khavinson short-peptide bioregulator program (preclinical).
What remains uncharacterized: concentration-response relationships in any specific in-vitro model system are not implied here. The literature cited above describes molecular-level observations only.
For research use only. Not for human or animal consumption.




